Drug Pricing Initiatives: On Nov. 19, 2021, the House of Representatives passed H.R. 5376 (the Build Back Better Act, or BBBA), the approximately $2.2 trillion social safety net, climate, and tax bill that includes measures related to drug pricing and healthcare. Among other things, the BBBA would provide new authority for Medicare to negotiate prices for certain drugs and would impose rebates under Medicare Part B and Part D, triggered by price increases that outpace inflation. The BBBA would also block the rebate rule proposed by the Trump Administration. The Nov. 19 vote followed the release by the Congressional Budget Office (CBO) of its score of the BBBA.